William Blair — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Neurogeneneurogene.comin𝕏NASDAQ: NGNEJun 2026
Neurogene develops gene therapy treatments for rare neurological diseases.
BiotechDeep TechDigital HealthLongevityMedical DevicesNew York, US
Rachel McMinn(Founder and Chief Executive Officer)inRachel McMinn, Ph.D.(Founder and Chief Executive Officer)
BoardCory Freedland(Director)inStephen Biggar(Director)
Co-investorsEcoR1 CapitalSamsara BioCapitalCasdin CapitalREDMILERTW Investments L.P.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.